Figure 4.
Summary of the pharmacological properties and drug design parameters for our HDP- and HTP-derived prodrugs. The scope of this study entails the optimization of HTP-based scaffolds through systematic investigation of sulfur position, lipid chain length, and newly integrated terminal motifs designed to resist CYP450-mediated ω-oxidation.